$2.63 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 89 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 104.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPRX | Buy | ROYALTY PHARMA PLC | $129,420,000 | +64.0% | 3,078,506 | +52.0% | 4.92% | +104.1% |
| LVS | Buy | LAS VEGAS SANDS CORP | $97,536,000 | +10.3% | 2,903,711 | +27.6% | 3.71% | +37.3% |
| HUM | Buy | HUMANA INC | $92,522,000 | +12.6% | 197,668 | +4.6% | 3.52% | +40.1% |
| IQV | Buy | IQVIA HLDGS INC | $85,070,000 | -4.9% | 392,045 | +1.4% | 3.24% | +18.5% |
| KURA | Buy | KURA ONCOLOGY INC | $73,632,000 | +17.6% | 4,017,000 | +3.2% | 2.80% | +46.4% |
| MA | Buy | MASTERCARD INCORPORATEDcl a | $65,970,000 | -3.3% | 209,111 | +9.5% | 2.51% | +20.4% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $65,941,000 | -3.0% | 121,375 | +5.5% | 2.51% | +20.8% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $63,907,000 | +52.3% | 951,986 | +86.5% | 2.43% | +89.5% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $51,474,000 | +50.2% | 2,321,800 | +97.2% | 1.96% | +86.9% |
| Buy | ARCELLX INC | $44,668,000 | +107.8% | 2,470,559 | +61.2% | 1.70% | +158.6% | |
| CP | New | CANADIAN PAC RY LTD | $44,282,000 | – | 634,056 | +100.0% | 1.68% | – |
| SQ | New | BLOCK INCcl a | $41,773,000 | – | 679,676 | +100.0% | 1.59% | – |
| INSM | Buy | INSMED INC | $40,992,000 | +32.3% | 2,078,680 | +57.7% | 1.56% | +64.8% |
| VTRS | New | VIATRIS INC | $40,643,000 | – | 3,881,900 | +100.0% | 1.54% | – |
| FIS | New | FIDELITY NATL INFORMATION SV | $40,632,000 | – | 443,240 | +100.0% | 1.54% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $38,816,000 | – | 486,661 | +100.0% | 1.48% | – |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $36,490,000 | +55.7% | 4,412,300 | +212.9% | 1.39% | +93.9% |
| MCK | Buy | MCKESSON CORP | $34,187,000 | +14.0% | 104,802 | +7.0% | 1.30% | +41.9% |
| DIS | New | DISNEY WALT CO | $33,127,000 | – | 350,926 | +100.0% | 1.26% | – |
| GPN | New | GLOBAL PMTS INC | $31,778,000 | – | 287,222 | +100.0% | 1.21% | – |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $31,206,000 | +33.0% | 1,784,200 | +24.4% | 1.19% | +65.6% |
| XOM | New | EXXON MOBIL CORP | $24,898,000 | – | 290,732 | +100.0% | 0.95% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $24,200,000 | -21.1% | 4,645,000 | +24.5% | 0.92% | -1.8% |
| EYPT | Buy | EYEPOINT PHARMACEUTICALS INC | $23,360,000 | -33.9% | 2,968,207 | +2.0% | 0.89% | -17.8% |
| MNST | New | MONSTER BEVERAGE CORP NEW | $23,157,000 | – | 249,802 | +100.0% | 0.88% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $20,983,000 | – | 1,125,112 | +100.0% | 0.80% | – |
| MTCH | New | MATCH GROUP INC NEW | $20,056,000 | – | 287,786 | +100.0% | 0.76% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $18,973,000 | -26.3% | 1,928,200 | +10.4% | 0.72% | -8.3% |
| Buy | MARINUS PHARMACEUTICALS INC | $16,992,000 | -34.3% | 3,510,831 | +26.9% | 0.65% | -18.2% | |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $16,443,000 | -73.4% | 3,355,624 | +28.4% | 0.62% | -66.9% |
| NOW | New | SERVICENOW INC | $12,136,000 | – | 25,521 | +100.0% | 0.46% | – |
| New | PEPGEN INC | $11,732,000 | – | 1,181,428 | +100.0% | 0.45% | – | |
| CMRX | Buy | CHIMERIX INC | $10,965,000 | -13.5% | 5,271,696 | +90.5% | 0.42% | +7.8% |
| TMUS | New | T-MOBILE US INC | $10,548,000 | – | 78,404 | +100.0% | 0.40% | – |
| CVX | New | CHEVRON CORP NEW | $10,302,000 | – | 71,154 | +100.0% | 0.39% | – |
| OXY | New | OCCIDENTAL PETE CORP | $10,165,000 | – | 172,642 | +100.0% | 0.39% | – |
| COP | New | CONOCOPHILLIPS | $9,951,000 | – | 110,798 | +100.0% | 0.38% | – |
| HRTX | Buy | HERON THERAPEUTICS INC | $9,070,000 | -44.7% | 3,251,048 | +13.3% | 0.34% | -31.1% |
| New | ALVOTECHordinary shares | $8,210,000 | – | 1,000,000 | +100.0% | 0.31% | – | |
| ORIC | Buy | ORIC PHARMACEUTICALS INC | $5,656,000 | +140.4% | 1,262,464 | +186.5% | 0.22% | +198.6% |
| COGT | New | COGENT BIOSCIENCES INC | $5,412,000 | – | 600,000 | +100.0% | 0.21% | – |
| ATAI | New | ATAI LIFE SCIENCES NV | $4,419,000 | – | 1,213,928 | +100.0% | 0.17% | – |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $2,864,000 | – | 58,734 | +100.0% | 0.11% | – |
| New | OPY ACQUISITION CORP I | $1,968,000 | – | 200,000 | +100.0% | 0.08% | – | |
| New | OPY ACQUISITION CORP I*w exp 09/22/202 | $18,000 | – | 72,605 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| AMAZON COM INC | 23 | Q2 2024 | 8.0% |
| UNITEDHEALTH GROUP INC | 23 | Q2 2024 | 5.7% |
| IQVIA HLDGS INC | 22 | Q2 2024 | 7.3% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| META PLATFORMS INC | 19 | Q2 2024 | 10.9% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| SUTRO BIOPHARMA INC | 18 | Q2 2024 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 18 | Q2 2024 | 1.8% |
| KEZAR LIFE SCIENCES INC | 18 | Q2 2024 | 1.4% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Erasca, Inc. | May 28, 2024 | 13,768,039 | 5.5% |
| ABEONA THERAPEUTICS INC. | May 13, 2024 | 3,685,503 | 9.3% |
| Benitec Biopharma Inc. | April 29, 2024 | 1,478,490 | 17.4% |
| Contineum Therapeutics, Inc. | April 15, 2024 | 1,720,000 | 9.3% |
| 89bio, Inc. | February 13, 2024 | 4,888,434 | 5.2% |
| Arcellx, Inc. | February 13, 2024 | 2,435,974 | 5.0% |
| Arcutis Biotherapeutics, Inc. | February 13, 2024 | 9,534,837 | 10.0% |
| Biohaven Ltd. | February 13, 2024 | 4,572,836 | 5.7% |
| EyePoint Pharmaceuticals, Inc. | February 13, 2024 | 4,774,389 | 10.0% |
| Fulcrum Therapeutics, Inc. | February 13, 2024 | 5,518,881 | 8.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-08-12 |
| SC 13G | 2024-05-28 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.